Back To Schedule
Wednesday, June 21 • 2:00pm - 3:15pm
#341: EMA Policy 0070: A Game Changer for Industry

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

EMA Policy 0070 is changing how clinical study reports (CSRs) and clinical data summaries are being written. EMA went 'live' with the public website on October 20, 2016, proactively posting CSRs as well as clinical information contained in a Marketing Authorization Application (MMA) following either a positive or negative decision by the CHMP on the MAA. EMA says it expects to publish 4,500 clinical reports per year. In March 2016, EMA published an external guidance on the implementation of Policy 0070. EMA revised the guidance in December 2016 which clarifies the agency’s expectations for the data required for submission. EMEA has stated that this external guidance is a ‘living document’. Phase II of Policy 0070 will include disclosure of Individual Patient Data (IPD).

Join Medical Writing Community for a follow up Round Table discussion at 4:00pm in the Community Corner.

Learning Objectives

Identify those areas within an organization impacted by Policy 0070; Discuss approaches companies are taking to comply with the policy; Discuss the challenges of Policy 0070; Describe EMA’s perspective on the external guidance; examine areas where changes will continue to evolve with Policy 0070.


Robert Paarlberg, MS


EMA Update
Marie-Helene Pinheiro, PharmD

EMA Policy 0070: Insights from the CRO Perspective
Dairine Dempsey, PhD, RPh

EMA Policy 0070: Industry Perspective
Julie G. Holtzople

avatar for Robert Paarlberg

Robert Paarlberg

Principal, Paarlberg & Associates LLC, United States
Robert Paarlberg is Principal of Paarlberg & Associates LLC, a consultancy specializing in regulatory policy, regulatory intelligence and global clinical trial disclosure strategy and operations. Prior to founding Paarlberg & Associates LLC, Bob worked at Pharmacia (Upjohn) and UCB... Read More →

avatar for Dairine Dempsey

Dairine Dempsey

Vice President, Strategic Regulatory Affairs, ICON plc.
Dr. Dempsey is VP, Strategic Regulatory Affairs at ICON plc. She is a PhD pharmacist with over 15 years’ experience as a pharmaceutical regulator. She previously held senior positions in the Irish competent authority for medicines where she represented Ireland in the EU & internationally... Read More →
avatar for Julie Holtzople

Julie Holtzople

Senior Director Clinical Transparency and Data Sharing, AstraZeneca, United States
Julie Holtzople is the Sr. Director of Clinical Transparency & Data Sharing for AstraZeneca and co-lead of the CREG CTT group. Julie received her Bachelors of Science in Business Administration at Virginia Polytechnic Institute. Julie has been with AstraZeneca for 14 years. Prior... Read More →
avatar for Marie-Helene Pinheiro

Marie-Helene Pinheiro

Industry Stakeholder Liaison, Corporate Stakeholders Department, European Medicines Agency (EMA)
Marie-Helene Pinheiro currently the Industry Stakeholder Liaison within the Corporate Stakeholders Department, at the European Medicines Agency. She is responsible for coordinating the Agency’s interaction with industry stakeholder organisations, for human and veterinary medicines... Read More →

Wednesday June 21, 2017 2:00pm - 3:15pm CDT
N227b McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  03: MedAffairs-SciComm, Forum